Interpace Biosciences, Inc.
IDXG
$0.95
$0.077.35%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 242.34% | -138.86% | -43.05% | 72.55% | -31.23% |
| Total Depreciation and Amortization | 6.03% | 4.74% | -9.95% | 11.64% | 0.53% |
| Total Amortization of Deferred Charges | 6.67% | 36.36% | -- | -- | -- |
| Total Other Non-Cash Items | -47.66% | 2,240.00% | -104.02% | -49.60% | 6,957.14% |
| Change in Net Operating Assets | -6.01% | 221.39% | 72.19% | -792.18% | 80.21% |
| Cash from Operations | 272.69% | -57.89% | 4.31% | -44.05% | 50.71% |
| Capital Expenditure | 41.79% | -- | -- | 75.29% | -164.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 41.79% | -- | -- | 75.29% | -164.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 10.00% | 33.33% | 0.00% | 0.00% | 25.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | 11.15% | 32.47% | 12.13% | -13.80% | 25.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 232.71% | -161.89% | 59.36% | -793.62% | 111.85% |